Home > HP (current issue) > News and features / News Centre | Search

PJ Online homeHospital Pharmacist
Vol 12 No 6 p197
June 2005

Hospital Pharmacist back issues

News summary


Responsibility for pharmacy issues now with new Minister

Jane Kennedy

Jane Kennedy: Minister now responsible for pharmacy portfolio

Jane Kennedy is the new Minister responsible for pharmacy issues at the Department of Health. She effectively takes over the pharmacy portfolio from Rosie Winterton.

As Minister of State for quality and patient safety, Ms Kennedy’s other responsibilities include the National Patient Safety Agency, standards, inspection and performance, clinical governance and quality issues. Also in her portfolio are clinical negligence, methicillin-resistant Staphylococcus aureus, reducing bureaucracy, the National Institute for Health and Clinical Excellence, genetics, the pharmaceutical industry, research and development, the Medicines and Healthcare Products Regulatory Agency and counter fraud.

For pharmacy issues, there is some overlap with the responsibilities of other ministers. For example, Ms Winterton’s new portfolio as Minister of State for health services includes emergency preparedness, cancer services, cardiac services, diabetes services, mental health, patient and public involvement, renal services and equality and diversity issues. She is also responsible for prison health care.

As well as new ministers, last month’s general election has also brought about proposals for new health care legislation potentially affecting hospital pharmacy. Bills announced in the Queen’s Speech included a NHS Redress Bill, which is designed to provide patients with a quick response to low value clinical negligence claims. This is designed to introduce a real alternative to litigation and avoid its associated delays and costs and to drive consistency across the NHS in the way claims are dealt with.

There will also be a Hospital Hygiene Bill, introducing a hygiene code of practice for all NHS bodies, independent health care providers and care homes in an attempt to reduce the incidence of methicillin-resistant Staphylococcus aureus. Inspectors, from the Healthcare Commission or the Commission for Social Care Inspection will be able to issue improvement orders. Consultation is to take place to determine further details about the hygiene code and what the enforcement sanctions will be.

Back to Top


©The Pharmaceutical Journal